EBRICTUS

Epidemiological Research Group in Stroke from Primary Care

This group comprises primary health care professionals from Terres de l'Ebre with an interest in the study of stroke from 2006, when the Stroke Code was implemented in this region. They collaborate with specialists in Cardiology and Neurology of the hospital Verge de la Cinta. Up to 2016, the research areas of this group were included in the PreCarTe Group: Cardiovascular Prevention Terres de l'Ebre, accredited by the Primary Care Research Institute IDIAP Jordi Gol (2012-2015) and more recently by the AGAUR, Generalitat de Catalunya SGR 2014-2016 (Agency for the Management of University and Research Grants, File 2014 SGR 1561). This group has developed a unique database through which three health regions (Terres de l'Ebre, Barcelona right and Vallès Occidental) have participated in the pilot of the implementation of the Atrial Fibrillation Health Care Route in Catalonia, under the auspices of the Catalan Health Service Department of Vascular Disease and the Terres de l’Ebre Emergencies Commission of the Catalan Health Service; and together with the Vall Hebron Institute of Research Foundation they are PIs in the Research in Atrial Fibrillation in Catalonia (AFRICAT); they also participate in the international, prospective, multicentre RIVER Registry (TRI08890), led by the Thrombosis Research Institute (London) to observe the management and short and long term results of non valvular atrial fibrillation treated with Rivaroxaban.

The group participates in the following projects

PI: Montero D. Desarrollo y evaluación de soluciones mHealth para monitorizar e implicar en autocuidado a pacientes cardiometabólicos. Duration: 2018 - 2021

PI: Ballesta Ors, Juan. Mejorando las estrategias para la prevención de impacto en la fibrilación auricular desconocida. Funding: ICS - Institut Català de la Salut. Duration: 2018 - 2020

PI: Clua Espuny, Josep Lluis. Long survival after ischemic stroke and thombolysis in Catalonia. Differences by sex. Funding: IDIAP Jordi Gol. Duration: 2017 - 2019

PI: Gavaldà Espelta, Ester. Efectivitat del model d'atenció integrada a persones en problemes crònics de salut: Salut+Social a la Ribera d'Ebre. Funding: Fundacio Doctor Ferran. Duration: 2017 - 2018

PI: Clua Espuny, Josep Lluis. Atrial Fibrillation Research in CATalonia (AFRICAT): sequential clinicelectro-biological screening among high risk individuals. Funding: Fundacio La Marato de TV3. Duration: 2016 - 2018

Group Publications

Gonzalez-Loyola F, Abellana R, Verdú-Rotellar JM, Bustamante Rangel A, Clua-Espuny JL, Muñoz MA. Mortality in heart failure with atrial fibrillation: Role of digoxin and diuretics. European journal of clinical investigation. 2018 Aug; doi:10.1111/eci.13014. Epub 2018 Aug 09. PMID:30091171. IF: 2,714.

López-Bru D, Palazón-Bru A, Folgado-de la Rosa DM, Gil-Guillén VF. A scoring system to predict recurrence in patients with differentiated thyroid cancer. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2019 Jan; 44(1):26-31. doi:10.1111/coa.13227. Epub 2018 Oct 09. PMID:30220101. IF: 2,523.

Márquez Contreras E, Márquez Rivero S, Rodríguez García E, López-García-Ramos L, Pastoriza Vilas JC, Baldonedo Suárez A, Gracia Diez C, Gil Guillén V, Martell Claros N; Compliance Group of Spanish Society of Hypertension (SEH-LELHA). Specific hypertension smartphone app to improve medication adherence in hypertension: a cluster-randomized trial. Current medical research and opinion. 2018 Nov; doi:10.1080/03007995.2018.1549026. Epub 2018 Nov 15. PMID:30431384. IF: 2,757.

Navarro-Pérez J, Orozco-Beltran D, Gil-Guillen V, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J, Tellez-Plaza M; ESCARVAL STUDY GROUP. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study. BMC cardiovascular disorders. 2018 09; 18(1):180. doi:10.1186/s12872-018-0914-1. Epub 2018 Sep 04. pmc:PMC6122181. PMID:30176799. IF: 1,832.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, de la Torre MP, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group. Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study. PloS one. 2018 ; 13(9):e0205047. doi:10.1371/journal.pone.0205047. Epub 2018 Sep 27. pmc:PMC6160173. PMID:30261062. IF: 2,806.

Palazón-Bru A, Carbayo-Herencia JA, Simarro-Rueda M, Artigao-Ródenas LM, Divisón-Garrote JA, Molina-Escribano F, Ponce-García I, Gil-Guillén VF; GEVA (Group of Vascular Diseases From Albacete). Comparison Between Non-High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol to Estimate Cardiovascular Risk Using a Multivariate Model. The Journal of cardiovascular nursing. 2018 Nov/Dec; 33(6):E17-E23. doi:10.1097/JCN.0000000000000534. PMID:30273261. IF: 2,105.

Paredes-Aracil E, Palazón-Bru A, Folgado-de la Rosa DM, Ots-Gutiérrez JR, Llorca-Ferrándiz C, Alonso-Hernández S, Coloma-Lidón JV, Gil-Guillén VF. A scoring system to predict recurrence in breast cancer patients. Surgical oncology. 2018 Dec; 27(4):681-687. doi:10.1016/j.suronc.2018.09.005. Epub 2018 Sep 18. PMID:30449493. IF: 3,304.

Román-Conejos E, Palazón-Bru A, Folgado-de la Rosa DM, Sánchez-Molla M, Rizo-Baeza MM, Gil-Guillén VF, Cortés-Castell E. A scoring system to detect fixed airflow limitation in smokers from simple easy-to-use parameters. Scientific reports. 2018 Sep; 8(1):13329. doi:10.1038/s41598-018-31198-8. Epub 2018 Sep 06. pmc:PMC6127215. PMID:30190580. IF: 4,259.

The group participates in the following publications

Carbayo Herencia JA, Simarro Rueda M, Palazón Bru A, Molina Escribano F, Ponce García I, Artigao Ródenas LM, Caldevilla Bernardo D, Divisón Garrote JA, Gil Guillén VF; Todos en nombre del Grupo de Enfermedades Vasculares de Albacete (GEVA). Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2018 Mar; 30(2):64-71. doi:10.1016/j.arteri.2017.10.003. Epub 2018 Feb 01. PMID:29395492.

García-Macías JA, Palazón-Bru A, Carbonell-Torregrosa MÁ, Navarro-Juan M, Gil-Guillén VF. Therapeutic inertia in anti-platelet therapy in patients with a cardiovascular event attended in an emergency department. Current medical research and opinion. 2018 May; doi:10.1080/03007995.2018.1469480. Epub 2018 May 21. PMID:29690773. IF: 2,757.

Gómez-Martínez L, Orozco-Beltrán D, Quesada JA, Bertomeu-González V, Gil-Guillén VF, López-Pineda A, Carratalá-Munuera C. Trends in Premature Mortality Due to Heart Failure by Autonomous Community in Spain: 1999 to 2013. Revista espanola de cardiologia (English ed.). 2018 Jul; 71(7):531-537. doi:10.1016/j.rec.2017.09.026. Epub 2018 Jan 10. PMID:29331563.

Gutiérrez Hervás AI, Cortés Castell E, Juste Ruíz M, Gil Guillén V, Rizo Baeza MM. Estimation of body fat among 2-to-7-year-old Spanish children by different skinfolds equations and waist-to-height ratio. Nutricion hospitalaria. 2017 Nov; 34(5):1299-1304. doi:10.20960/nh.1111. Epub 2017 Nov 17. PMID:29280643. IF: 0,747.

Gutiérrez-Hervás A, Cortés-Castell E, Juste-Ruíz M, Palazón-Bru A, Gil-Guillén V, Rizo-Baeza MM. Physical activity values in two- to seven-year-old children measured by accelerometer over five consecutive 24-hour days. Nutricion hospitalaria. 2018 Jun; 35(3):527-532. doi:10.20960/nh.1403. Epub 2018 Jun 27. PMID:29974757. IF: 0,747.

Jover-Esplá AG, Palazón-Bru A, Folgado-de la Rosa DM, de Juan-Herrero J, Gil-Guillén VF. A scoring system to predict 5-year mortality in patients diagnosed with laryngeal glottic cancer. European journal of cancer care. 2018 Jul; 27(4):e12860. doi:10.1111/ecc.12860. Epub 2018 Jun 05. PMID:29870075. IF: 2,104.

Jover-Esplá AG, Palazón-Bru A, Folgado-de la Rosa DM, Severá-Ferrándiz G, Sancho-Mestre M, de Juan-Herrero J, Gil-Guillén VF. A predictive model for recurrence in patients with glottic cancer implemented in a mobile application for Android. Oral oncology. 2018 May; 80:82-88. doi:10.1016/j.oraloncology.2018.03.021. Epub 2018 Apr 04. PMID:29706192. IF: 4,794.

Lopez-Pineda A, Cordero A, Carratala-Munuera C, Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, Gil-Guillen VF, Bertomeu-Martinez V. Association analysis between hyperuricemia and long term mortality after acute coronary syndrome in three subgroups of patients. Data in brief. 2018 Apr; 17:885-889. doi:10.1016/j.dib.2018.01.101. Epub 2018 Feb 05. pmc:PMC5834648. PMID:29516035.

Lopez-Pineda A, Cordero A, Carratala-Munuera C, Orozco-Beltran D, Quesada JA, Bertomeu-Gonzalez V, Gil-Guillen VF, Bertomeu-Martinez V. Hyperuricemia as a prognostic factor after acute coronary syndrome. Atherosclerosis. 2018 02; 269:229-235. doi:10.1016/j.atherosclerosis.2018.01.017. Epub 2018 Jan 17. PMID:29407598. IF: 4,239.

Márquez-Contreras E, López García-Ramos L, Martell-Claros N, Gil-Guillen VF, Márquez-Rivero S, Pérez-López E, Garrido-Lopez MA, Farauste C, López-Pineda A, Casado-Martinez JJ, Orozco-Beltran D, Quesada JA, Carratalá-Munuera C. Validation of the electronic prescription as a method for measuring treatment adherence in hypertension. Patient education and counseling. 2018 09; 101(9):1654-1660. doi:10.1016/j.pec.2018.04.009. Epub 2018 Apr 23. PMID:29731180. IF: 2,429.

Márquez-Contreras E, Martell-Claros N, Márquez-Rivero S, Hermida-Campa E, Gracia-Diez C, Sanchez-López E, Gil-Guillén V; Compliance and Inertia Working Group, Spanish Society of Hypertension (SEH-LELHA). Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study). Current medical research and opinion. 2018 Feb; doi:10.1080/03007995.2018.1435519. Epub 2018 Feb 21. PMID:29384410. IF: 2,757.

Martínez-Díaz AM, Palazón-Bru A, Folgado-de la Rosa DM, Ramírez-Prado D, Navarro-Juan M, Pérez-Ramírez N, Gil-Guillén VF. A one-year risk score to predict all-cause mortality in hypertensive inpatients. European journal of internal medicine. 2019 01; 59:77-83. doi:10.1016/j.ejim.2018.07.010. Epub 2018 Jul 13. PMID:30007839. IF: 2,960.

Palazón-Bru A, Colomina-Climent F, Dólera-Moreno C, Folgado-de la Rosa DM, Gil-Guillén VF. A brief comment about predictive models for mortality in intensive care units. Acta anaesthesiologica Scandinavica. 2018 Mar; 62(3):404. doi:10.1111/aas.13076. Epub 2018 Jan 24. PMID:29363094. IF: 2,438.

Palazón-Bru A, Rizo-Baeza MM, Martínez-Segura A, Folgado-de la Rosa DM, Gil-Guillén VF, Cortés-Castell E. Screening Tool to Determine Risk of Having Muscle Dysmorphia Symptoms in Men Who Engage in Weight Training at a Gym. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine. 2018 03; 28(2):168-173. doi:10.1097/JSM.0000000000000422. PMID:29271781. IF: 2,189.

Palazón-Bru A, Tomás-Rodríguez MI, Toledo-Marhuenda JV, Gil-Guillén VF. Response to the Comment on: Factors Associated with Increased Pain in Primary Dysmenorrhea: Analysis Using a Multivariate Ordered Logistic Regression Model. Journal of pediatric and adolescent gynecology. 2018 Aug; 31(4):433. doi:10.1016/j.jpag.2018.03.009. PMID:29891051. IF: 1,576.

Pepió Vilaubí JM, Orozco-Beltrán D, Gonçalves AQ, Rodriguez Cumplido D, Aguilar Martin C, Lopez-Pineda A, Gil-Guillen VF, Quesada JA, Carratala-Munuera C. Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study. Int J Environ Res Public Health. 2018 Jun 11;15(6). pii: E1233. doi: 10.3390/ijerph15061233. PubMed PMID: 29891821; PubMed Central PMCID: PMC6025527. IF: 2,101.

Pérez-Jover V, Mira JJ, Carratala-Munuera C, Gil-Guillen VF, Basora J, López-Pineda A, Orozco-Beltrán D. Inappropriate Use of Medication by Elderly, Polymedicated, or Multipathological Patients with Chronic Diseases. International journal of environmental research and public health. 2018 Feb; 15(2). doi:10.3390/ijerph15020310. Epub 2018 Feb 10. pmc:PMC5858379. PMID:29439425. IF: 2,101.

Indicators

Indicator

2018

Researchers with PhD

9

Total number of projects in which group members have participated

5

Total number of projects in which the PI of the project has belonged to the group

3

Total Funding

322.108,50€

Scientific publications in indexed journals

20

Total Impact factor

56,24

Nº of articles in Q1 journals

14

Q1 IF

42,508

Nº of articles in Q2 journals

4

Q2 IF

8,829

Anar a l'inici